Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS07 - Industry Symposium Sponsored by Roche: Expert Perspectives on the Management of Lung Cancer

    • 16:45 - 17:45
    • 1/28/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS07.01 - The Past, Present and Future of Biomarker-Driven Advanced NSCLC

      16:45 - 17:15  |  Presenter: Benjamin Solomon, Shirish Madhav Gadgeel, Solange Peters

      • Abstract

      No abstract available for this presentation

    • +

      IS07.02 - Future Directions for Cancer Immunotherapy: Resectable NSCLC and Novel Combinations in Lung Cancer

      17:15 - 17:45  |  Presenter: Ross Soo, Solange Peters, Martin Reck

      • Abstract

      No abstract available for this presentation

  • +

    P03 - Early Stage/Localized Disease - Clinical Trials in Progress

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P03.03 - MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery

      00:00 - 00:00  |  Presenter: Solange Peters

      • Abstract

      Loading...

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P09.18 - COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)

      00:00 - 00:00  |  Presenter: Umit Tapan

      • Abstract

      Loading...

  • +

    P83 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Targeted Therapy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      P83.02 - Niraparib + Pembrolizumab (Pembro) Versus Placebo + Pembro 1L Maintenance Therapy in Advanced NSCLC: ZEAL-1L Phase III Study

      00:00 - 00:00  |  Presenter: Suresh S. Ramalingam

      • Abstract

      Loading...

  • +

    ES09 - Biomarkers in Immunotherapy

    • 09:15 - 10:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      ES09.03 - Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy

      09:15 - 09:25  |  Presenter: Solange Peters

      • Abstract

      Loading...

  • +

    MA06 - Molecular Developments and Novel Treatments in Mesothelioma and Thymoma

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      MA06.03 - Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape

      14:15 - 14:20  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...